Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

…, V Liakina, YS Lim, B Luksic, A Mahomed… - The lancet …, 2017 - thelancet.com
Background The 69th World Health Assembly approved the Global Health Sector Strategy
to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the …

Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19

…, S Stacey, L Murray, GA Richards, I Kalla, A Mahomed… - Journal of Infection, 2021 - Elsevier
Background: South Africa has the highest prevalence of HIV in the world and to date has
recorded the highest number of cases of COVID-19 in Africa. There is uncertainty as to what the …

Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5, 6): an open-label, multicentre, phase …

…, BB Yao, T Nguyen, F Wong, A Mahomed… - The Lancet …, 2019 - thelancet.com
Background The pangenotypic direct-acting antiviral regimen of glecaprevir coformulated
with pibrentasvir is approved to treat chronic hepatitis C virus (HCV) genotype 1–6 infection in …

Living donor liver transplant from an HIV-positive mother to her HIV-negative child: opening up new therapeutic options

…, J Loveland, B Ströbele, S Rambarran, A Mahomed… - Aids, 2018 - journals.lww.com
Objective: Transplant a liver from an HIV-positive mother to her HIV-negative child to save
the child's life. Design: A unique case of living donor liver transplantation from an HIV-positive …

[PDF][PDF] Myosteatosis, the more significant predictor of outcome: an analysis of the impact of myosteatosis, sarcopenia, and sarcopenic obesity on liver transplant …

…, J Fabian, KR Hari, L Lorentz, A Mahomed… - Exp Clin …, 2021 - researchgate.net
Objectives: In high-income countries, myosteatosis, sarcopenia, and obesity with sarcopenia
(sarcopenic obesity) are associated with adverse outcomes after liver transplantation. In …

Glycaemic characteristics and outcomes of COVID-19 patients admitted to a tertiary hospital in Johannesburg

…, S Bolon, O Smith, A Mahomed… - Wits Journal of Clinical …, 2020 - journals.co.za
Background: Diabetes is reported to be a risk factor for severe disease with COVID-19. Objective:
To describe the glycaemic characteristics and clinical outcomes in patients with COVID-…

[HTML][HTML] Age significantly influences the sensitivity of SARS-CoV-2 rapid antibody assays

…, J Venturas, I Kalla, N Diana, A Mahomed… - International Journal of …, 2021 - Elsevier
BACKGROUND Point-of-care serological assays are a promising tool in COVID-19 diagnostics
but do have limitations. Our study evaluated the sensitivity of five rapid antibody assays …

Acute kidney injury during the COVID-19 pandemic–experience from two tertiary centres in South Africa

…, L Boloko, T De Wet, G Paget, A Mahomed… - Wits Journal of Clinical …, 2020 - journals.co.za
Background: The first case of SARS-CoV-2 in South Africa [SA] was documented in March
2020. By October, the total cases for the Western Cape and Gauteng Provinces were 331,425 …

Clinical characteristics of the first 100 COVID-19 patients admitted to a tertiary hospital in Johannesburg, South Africa

…, J Edgar, V Naidoo, A Mahomed… - Wits Journal of Clinical …, 2020 - journals.co.za
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the
disease it causes, coronavirus disease 2019 (COVID-19), has spread rapidly across the globe …

COVID‑19 in pregnant women in South Africa: A retrospective review

…, N Sanyika, K Mall, T Ramdin, A Mahomed… - South African Medical …, 2022 - ajol.info
Background. The majority of maternal deaths in South Africa (SA) occur as a result of non-pregnancy-related
infections (NPRI). Pregnancy is a known risk factor in severe COVID‑19, …